MedPath

Verification for the efficacy of third look endoscopy to prevent delayed postoperative bleeding after gastric endoscopic submucosal dissection in patients with antithrombotic drugs -a prospective study

Phase 2
Conditions
early gastric cancer / adenoma
Registration Number
JPRN-UMIN000025607
Lead Sponsor
Yokohama City University Medical Center
Brief Summary

In total, 96 patients and 114 specimens were finally evaluated. The overall PDB rate was 7.9% (9/114) [90%CI: 4.7-13.1, P = 0.005], while the late-and early-onset PDB rates (L-PDB and E-PDB) were 5.3% [90%CI: 2.7-9.9, P < 0.0001] and 2.6% [90%CI: 1.1-6.4, P = 0.51], respectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

(1) Patient with severe infection (2) Patient who are pregnant, may be pregnant, or prefer pregnancy during treatment (3)for Mental disease, dementia,it is difficult to participate study (4) Patient with unstable angina, or myocardial infarction within 6 months. (5)Patient with respiratory diseases requiring continuous oxygen therapy (6)Patient with uncontrollable hypertension (7)Patient with uncontrollable Diabetes (8)anemia requiring transfusion(Hb<7.0g/dl), Easy to bleed for low platelet (Plt<50000) (9) Patient judged inappropriate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Overall delayed bleeding rate
Secondary Outcome Measures
NameTimeMethod
the early phase delayed bleeding rate the late phase delayed bleeding rate the delayed bleeding rate compared with the historical control group using propensity score matching.
© Copyright 2025. All Rights Reserved by MedPath